Diabetes insipidus epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
 
(6 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Diabetes insipidus}}
{{Diabetes insipidus}}
{{CMG}}
{{CMG}}; {{AE}} {{DAMI}}
 
{{PleaseHelp}}


==Overview==
==Overview==
The [[prevalence]] of diabetes insipidus is estimated to be 3:100,000 individuals worldwide. The [[prevalence]] and [[incidence]] of both [[Central diabetes insipidus|central]] and [[Nephrogenic diabetes insipidus|nephrogenic DI]] does not vary by gender. Similarly, no significant racial predilection in [[prevalence]] among ethnic groups have been found.
The [[prevalence]] of diabetes insipidus is estimated to be 3 cases per 100,000 individuals worldwide. The [[prevalence]] and [[incidence]] of both [[Central diabetes insipidus|central]] and [[Nephrogenic diabetes insipidus|nephrogenic DI]] does not vary by gender. Similarly, no significant racial predilection in [[prevalence]] has been observed. With both [[Central diabetes insipidus|central]] and [[Nephrogenic diabetes insipidus|nephrogenic diabetes inispidus]], inherited causes account for approximately 1-2% of all cases. The incidence of [[nephrogenic diabetes insipidus]] caused by [[Aquaporin 2|AQP2]] mutations is about 1 in 20 million births.
 
With both [[Central diabetes insipidus|central]] and [[Nephrogenic diabetes insipidus|nephrogenic diabetes inispidus]], inherited causes account for approximately 1-2% of all cases. An incidence of about 1 in 20 million births for [[nephrogenic diabetes insipidus]] caused by AQP2 mutations has been documented.<ref name="pmid22248325">{{cite journal |vauthors=Verkman AS |title=Aquaporins in clinical medicine |journal=Annu. Rev. Med. |volume=63 |issue= |pages=303–16 |year=2012 |pmid=22248325 |pmc=3319404 |doi=10.1146/annurev-med-043010-193843 |url=}}</ref>


==Epidemiology and Demographics==
==Epidemiology and Demographics==


===Prevalence===
===Prevalence===
The [[prevalence]] of diabetes insipidus is estimated to be 3:100,000 individuals worldwide.
The [[prevalence]] of diabetes insipidus is estimated to be 3 cases per 100,000 individuals worldwide.<ref name="pmid22248325">{{cite journal |vauthors=Verkman AS |title=Aquaporins in clinical medicine |journal=Annu. Rev. Med. |volume=63 |issue= |pages=303–16 |year=2012 |pmid=22248325 |pmc=3319404 |doi=10.1146/annurev-med-043010-193843 |url=}}</ref>


===Incidence===
===Incidence===
Line 22: Line 18:


===Age===
===Age===
Diabetes insipidus has been identified in all age groups from infancy to adulthood.
Diabetes insipidus has been identified in all age groups from [[infancy]] to [[Adult|adulthood]].


===Gender===
===Gender===
The [[prevalence]] and [[incidence]] of both [[Central diabetes insipidus|central]] and [[nephrogenic diabetes insipidus]] does not vary by gender.
The [[prevalence]] and [[incidence]] of both [[Central diabetes insipidus|central]] and [[nephrogenic diabetes insipidus]] does not vary by gender.<ref name="pmid22248325" />


===Race===
===Race===
There is no racial predilection for diabetes insipidus.
There is no [[racial]] predilection for diabetes insipidus.


===Developed countries===
===Developed countries===
Line 44: Line 40:
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Nephrology]]
[[Category:Nephrology]]
[[Category:Needs content]]
[[Category:Needs overview]]

Latest revision as of 21:16, 27 October 2017

Diabetes insipidus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diabetes insipidus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diabetes insipidus epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diabetes insipidus epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diabetes insipidus epidemiology and demographics

CDC on Diabetes insipidus epidemiology and demographics

Diabetes insipidus epidemiology and demographics in the news

Blogs on Diabetes insipidus epidemiology and demographics

Directions to Hospitals Treating Diabetes insipidus

Risk calculators and risk factors for Diabetes insipidus epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

The prevalence of diabetes insipidus is estimated to be 3 cases per 100,000 individuals worldwide. The prevalence and incidence of both central and nephrogenic DI does not vary by gender. Similarly, no significant racial predilection in prevalence has been observed. With both central and nephrogenic diabetes inispidus, inherited causes account for approximately 1-2% of all cases. The incidence of nephrogenic diabetes insipidus caused by AQP2 mutations is about 1 in 20 million births.

Epidemiology and Demographics

Prevalence

The prevalence of diabetes insipidus is estimated to be 3 cases per 100,000 individuals worldwide.[1]

Incidence

The incidence of diabetes insipidus is 1 in 20 million births for nephrogenic diabetes insipidus caused by AQP2 mutations.[1]

Case Fatality Rate

The case-fatality rate of diabetes insipidus is unknown.

Age

Diabetes insipidus has been identified in all age groups from infancy to adulthood.

Gender

The prevalence and incidence of both central and nephrogenic diabetes insipidus does not vary by gender.[1]

Race

There is no racial predilection for diabetes insipidus.

Developed countries

Incidence, prevalence, and geographical distribution of both central diabetes insipidus and nephrogenic diabetes insipidus does not vary.

Developing countries

Incidence, prevalence, and geographical distribution of both central diabetes insipidus and nephrogenic diabetes insipidus does not vary.

References

  1. 1.0 1.1 1.2 Verkman AS (2012). "Aquaporins in clinical medicine". Annu. Rev. Med. 63: 303–16. doi:10.1146/annurev-med-043010-193843. PMC 3319404. PMID 22248325.


Template:WikiDoc Sources